Bevacizumab and Retinal Vascular Occlusions

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

• Phase: Phase 3

Details

• Lead Sponsor: Asociación para Evitar la Ceguera en México

Criteria

Inclusion Criteria:

• Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria:

• Previous surgery

• Uveitis

• Glaucoma